Macrocyclic indoles as hepatitis C virus inhibitors
US8524716B2 · kind B2 · utility
24Cited by
4References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 2008 |
| Grant date | Sep 3, 2013 |
| Priority date | — |
| Expiry date | Feb 2, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to inhibitors of HCV replication of formula (I), the N-oxide forms, the pharmaceutically acceptable addition salts, the quaternary amines and the stereochemically isomeric forms thereof,wherein R1; R3; and R4 have the meaning defined in the claims.The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.